[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100508163":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":186,"centralContacts":191,"locations":192,"responsibleParty":538,"collaborators":191,"id":540,"slug":541,"hasResults":542,"nctId":543,"briefTitle":544,"officialTitle":545,"acronym":191,"eligibilityCriteria":546,"healthyVolunteers":542,"sex":547,"minAge":548,"maxAge":191,"enrollmentInfo":549,"targetDuration":191,"studyType":552,"phases":553,"briefSummary":556,"conditions":557,"keywords":191,"overallStatus":195,"whyStopped":191,"lastUpdateSubmitDate":571,"lastUpdatePostDateStruct":572,"startDateStruct":575,"completionDateStruct":577,"leadSponsor":579,"locationsCount":580},{"fullName":5,"class":6},"National Cancer Institute (NCI)","NIH",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment (nivolumab and ipilimumab)","EXPERIMENTAL","See detailed description",[13,14,15,16,17,18,19,20,21],"Procedure: Biopsy Procedure","Procedure: Biospecimen Collection","Procedure: Computed Tomography","Biological: Ipilimumab","Procedure: Kidney Biopsy","Procedure: Magnetic Resonance Imaging","Biological: Nivolumab","Drug: Prednisone","Drug: Sirolimus",[23,32,41,58,74,81,101,122,170],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"PROCEDURE","Biopsy Procedure","Undergo tumor biopsy",[9],[29,30,31],"Biopsy","BIOPSY_TYPE","Bx",{"type":24,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"Biospecimen Collection","Undergo blood sample collection",[9],[37,38,39,40],"Biological Sample Collection","Biospecimen Collected","Sample Collection","Specimen Collection",{"type":24,"name":42,"description":43,"armGroupLabels":44,"otherNames":45},"Computed Tomography","Undergo CT scan",[9],[46,47,48,49,50,51,52,53,54,55,56,57],"CAT","CAT Scan","Computed Axial Tomography","Computerized Axial Tomography","Computerized axial tomography (procedure)","Computerized Tomography","Computerized Tomography (CT) scan","CT","CT Scan","Diagnostic CAT Scan","Diagnostic CAT Scan Service Type","tomography",{"type":59,"name":60,"description":61,"armGroupLabels":62,"otherNames":63},"BIOLOGICAL","Ipilimumab","Given IV",[9],[64,65,66,67,68,69,70,71,72,73],"Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody","BMS 734016","BMS-734016","BMS734016","Ipilimumab Biosimilar CS1002","MDX 010","MDX-010","MDX-CTLA4","MDX010","Yervoy",{"type":24,"name":75,"description":76,"armGroupLabels":77,"otherNames":78},"Kidney Biopsy","Undergo kidney biopsy",[9],[79,80],"Biopsy of Kidney","Renal Biopsy",{"type":24,"name":82,"description":83,"armGroupLabels":84,"otherNames":85},"Magnetic Resonance Imaging","Undergo MRI",[9],[86,87,88,89,90,91,92,93,94,95,96,97,98,99,100],"Magnetic Resonance","Magnetic Resonance Imaging (MRI)","Magnetic resonance imaging (procedure)","Magnetic Resonance Imaging Scan","Medical Imaging, Magnetic Resonance \u002F Nuclear Magnetic Resonance","MR","MR Imaging","MRI","MRI Scan","MRIs","NMR Imaging","NMRI","Nuclear Magnetic Resonance Imaging","sMRI","Structural MRI",{"type":59,"name":102,"description":61,"armGroupLabels":103,"otherNames":104},"Nivolumab",[9],[105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121],"ABP 206","BCD-263","BMS 936558","BMS-936558","BMS936558","CMAB819","MDX 1106","MDX-1106","MDX1106","NIVO","Nivolumab Biosimilar ABP 206","Nivolumab Biosimilar BCD-263","Nivolumab Biosimilar CMAB819","ONO 4538","ONO-4538","ONO4538","Opdivo",{"type":123,"name":124,"description":125,"armGroupLabels":126,"otherNames":127},"DRUG","Prednisone","Given PO",[9],[128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169],".delta.1-Cortisone","1, 2-Dehydrocortisone","Adasone","Cortancyl","Dacortin","DeCortin","Decortisyl","Decorton","Delta 1-Cortisone","Delta-Dome","Deltacortene","Deltacortisone","Deltadehydrocortisone","Deltasone","Deltison","Deltra","Econosone","Lisacort","Meprosona-F","Metacortandracin","Meticorten","Ofisolona","Orasone","Panafcort","Panasol-S","Paracort","Perrigo Prednisone","PRED","Predicor","Predicorten","Prednicen-M","Prednicort","Prednidib","Prednilonga","Predniment","Prednisone Intensol","Prednisonum","Prednitone","Promifen","Rayos","Servisone","SK-Prednisone",{"type":123,"name":171,"description":125,"armGroupLabels":172,"otherNames":173},"Sirolimus",[9],[174,175,176,177,178,179,180,181,182,183,184,185],"AY 22989","AY-22989","AY22989","RAPA","Rapamune","Rapamycin","SILA 9268A","SILA-9268A","SILA9268A","WY 090217","WY-090217","WY090217",[187],{"name":188,"affiliation":189,"role":190},"Evan J Lipson","JHU Sidney Kimmel Comprehensive Cancer Center LAO","PRINCIPAL_INVESTIGATOR",null,[193,215,229,240,248,264,279,292,304,316,325,338,350,361,377,392,407,422,437,449,461,470,479,495,507,522],{"facility":194,"status":195,"city":196,"state":197,"zip":198,"country":199,"countryCode":200,"cosmosGeoPoint":201,"geoPoint":206,"contacts":207},"UC San Diego Moores Cancer Center","RECRUITING","La Jolla","California","92093","United States","US",{"type":202,"coordinates":203},"Point",[204,205],-117.2742,32.84727,{"lat":205,"lon":204},[208,213],{"name":209,"role":210,"phone":211,"phoneExt":191,"email":212},"Site Public Contact","CONTACT","858-822-5354","cancercto@ucsd.edu",{"name":214,"role":190,"phone":191,"phoneExt":191,"email":191},"Soo Park",{"facility":216,"status":195,"city":217,"state":197,"zip":218,"country":199,"countryCode":200,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Keck Medicine of USC Koreatown","Los Angeles","90020",{"type":202,"coordinates":220},[221,222],-118.24368,34.05223,{"lat":222,"lon":221},[225,227],{"name":209,"role":210,"phone":226,"phoneExt":191,"email":191},"213-388-0908",{"name":228,"role":190,"phone":191,"phoneExt":191,"email":191},"Gino K. In",{"facility":230,"status":195,"city":217,"state":197,"zip":231,"country":199,"countryCode":200,"cosmosGeoPoint":232,"geoPoint":234,"contacts":235},"Los Angeles General Medical Center","90033",{"type":202,"coordinates":233},[221,222],{"lat":222,"lon":221},[236,239],{"name":209,"role":210,"phone":237,"phoneExt":191,"email":238},"323-865-0451","uscnorrisinfo@med.usc.edu",{"name":228,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":241,"status":195,"city":217,"state":197,"zip":231,"country":199,"countryCode":200,"cosmosGeoPoint":242,"geoPoint":244,"contacts":245},"USC \u002F Norris Comprehensive Cancer Center",{"type":202,"coordinates":243},[221,222],{"lat":222,"lon":221},[246,247],{"name":209,"role":210,"phone":237,"phoneExt":191,"email":191},{"name":228,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":249,"status":195,"city":250,"state":251,"zip":252,"country":199,"countryCode":200,"cosmosGeoPoint":253,"geoPoint":257,"contacts":258},"Sibley Memorial Hospital","Washington D.C.","District of Columbia","20016",{"type":202,"coordinates":254},[255,256],-77.03637,38.89511,{"lat":256,"lon":255},[259,262],{"name":209,"role":210,"phone":260,"phoneExt":191,"email":261},"202-243-2373","jquiver1@jhmi.edu",{"name":263,"role":190,"phone":191,"phoneExt":191,"email":191},"Evan J. Lipson",{"facility":265,"status":195,"city":266,"state":267,"zip":268,"country":199,"countryCode":200,"cosmosGeoPoint":269,"geoPoint":273,"contacts":274},"UM Sylvester Comprehensive Cancer Center at Aventura","Aventura","Florida","33180",{"type":202,"coordinates":270},[271,272],-80.13921,25.95648,{"lat":272,"lon":271},[275,277],{"name":209,"role":210,"phone":276,"phoneExt":191,"email":191},"954-461-2180",{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},"Jose Lutzky",{"facility":280,"status":195,"city":281,"state":267,"zip":282,"country":199,"countryCode":200,"cosmosGeoPoint":283,"geoPoint":287,"contacts":288},"UM Sylvester Comprehensive Cancer Center at Coral Gables","Coral Gables","33146",{"type":202,"coordinates":284},[285,286],-80.26838,25.72149,{"lat":286,"lon":285},[289,291],{"name":209,"role":210,"phone":290,"phoneExt":191,"email":191},"305-243-2647",{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":293,"status":195,"city":294,"state":267,"zip":295,"country":199,"countryCode":200,"cosmosGeoPoint":296,"geoPoint":300,"contacts":301},"UM Sylvester Comprehensive Cancer Center at Deerfield Beach","Deerfield Beach","33442",{"type":202,"coordinates":297},[298,299],-80.09977,26.31841,{"lat":299,"lon":298},[302,303],{"name":209,"role":210,"phone":290,"phoneExt":191,"email":191},{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":305,"status":195,"city":306,"state":267,"zip":307,"country":199,"countryCode":200,"cosmosGeoPoint":308,"geoPoint":312,"contacts":313},"University of Miami Miller School of Medicine-Sylvester Cancer Center","Miami","33136",{"type":202,"coordinates":309},[310,311],-80.19366,25.77427,{"lat":311,"lon":310},[314,315],{"name":209,"role":210,"phone":290,"phoneExt":191,"email":191},{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":317,"status":195,"city":306,"state":267,"zip":318,"country":199,"countryCode":200,"cosmosGeoPoint":319,"geoPoint":321,"contacts":322},"UM Sylvester Comprehensive Cancer Center at Kendall","33176",{"type":202,"coordinates":320},[310,311],{"lat":311,"lon":310},[323,324],{"name":209,"role":210,"phone":290,"phoneExt":191,"email":191},{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":326,"status":195,"city":327,"state":267,"zip":328,"country":199,"countryCode":200,"cosmosGeoPoint":329,"geoPoint":333,"contacts":334},"University of Miami Sylvester Comprehensive Cancer Center at Sole Mia","North Miami","33181",{"type":202,"coordinates":330},[331,332],-80.18671,25.89009,{"lat":332,"lon":331},[335,337],{"name":209,"role":210,"phone":191,"phoneExt":191,"email":336},"kginnity@med.miami.edu",{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":339,"status":195,"city":340,"state":267,"zip":341,"country":199,"countryCode":200,"cosmosGeoPoint":342,"geoPoint":346,"contacts":347},"UM Sylvester Comprehensive Cancer Center at Plantation","Plantation","33324",{"type":202,"coordinates":343},[344,345],-80.23184,26.13421,{"lat":345,"lon":344},[348,349],{"name":209,"role":210,"phone":290,"phoneExt":191,"email":191},{"name":278,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":351,"status":352,"city":353,"state":354,"zip":355,"country":199,"countryCode":200,"cosmosGeoPoint":356,"geoPoint":360,"contacts":191},"Emory University Hospital\u002FWinship Cancer Institute","ACTIVE_NOT_RECRUITING","Atlanta","Georgia","30322",{"type":202,"coordinates":357},[358,359],-84.38798,33.749,{"lat":359,"lon":358},{"facility":362,"status":195,"city":363,"state":364,"zip":365,"country":199,"countryCode":200,"cosmosGeoPoint":366,"geoPoint":370,"contacts":371},"Northwestern University","Chicago","Illinois","60611",{"type":202,"coordinates":367},[368,369],-87.65005,41.85003,{"lat":369,"lon":368},[372,375],{"name":209,"role":210,"phone":373,"phoneExt":191,"email":374},"312-695-1301","cancer@northwestern.edu",{"name":376,"role":190,"phone":191,"phoneExt":191,"email":191},"Sunandana Chandra",{"facility":378,"status":195,"city":379,"state":364,"zip":380,"country":199,"countryCode":200,"cosmosGeoPoint":381,"geoPoint":385,"contacts":386},"Memorial Hospital East","Shiloh","62269",{"type":202,"coordinates":382},[383,384],-89.89732,38.56144,{"lat":384,"lon":383},[387,390],{"name":209,"role":210,"phone":388,"phoneExt":191,"email":389},"314-747-9912","dschwab@wustl.edu",{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},"George Ansstas",{"facility":393,"status":195,"city":394,"state":395,"zip":396,"country":199,"countryCode":200,"cosmosGeoPoint":397,"geoPoint":401,"contacts":402},"University of Kentucky\u002FMarkey Cancer Center","Lexington","Kentucky","40536",{"type":202,"coordinates":398},[399,400],-84.47772,37.98869,{"lat":400,"lon":399},[403,405],{"name":209,"role":210,"phone":404,"phoneExt":191,"email":191},"859-257-3379",{"name":406,"role":190,"phone":191,"phoneExt":191,"email":191},"Ruta Arays",{"facility":408,"status":195,"city":409,"state":410,"zip":411,"country":199,"countryCode":200,"cosmosGeoPoint":412,"geoPoint":416,"contacts":417},"Johns Hopkins University\u002FSidney Kimmel Cancer Center","Baltimore","Maryland","21287",{"type":202,"coordinates":413},[414,415],-76.61219,39.29038,{"lat":415,"lon":414},[418,421],{"name":209,"role":210,"phone":419,"phoneExt":191,"email":420},"410-955-8804","jhcccro@jhmi.edu",{"name":263,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":423,"status":195,"city":424,"state":425,"zip":426,"country":199,"countryCode":200,"cosmosGeoPoint":427,"geoPoint":431,"contacts":432},"Siteman Cancer Center at Saint Peters Hospital","City of Saint Peters","Missouri","63376",{"type":202,"coordinates":428},[429,430],-90.62651,38.80033,{"lat":430,"lon":429},[433,436],{"name":209,"role":210,"phone":434,"phoneExt":191,"email":435},"800-600-3606","info@siteman.wustl.edu",{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":438,"status":195,"city":439,"state":425,"zip":440,"country":199,"countryCode":200,"cosmosGeoPoint":441,"geoPoint":445,"contacts":446},"Siteman Cancer Center at West County Hospital","Creve Coeur","63141",{"type":202,"coordinates":442},[443,444],-90.42262,38.66089,{"lat":444,"lon":443},[447,448],{"name":209,"role":210,"phone":434,"phoneExt":191,"email":435},{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":450,"status":195,"city":451,"state":425,"zip":452,"country":199,"countryCode":200,"cosmosGeoPoint":453,"geoPoint":457,"contacts":458},"Washington University School of Medicine","St Louis","63110",{"type":202,"coordinates":454},[455,456],-90.19789,38.62727,{"lat":456,"lon":455},[459,460],{"name":209,"role":210,"phone":434,"phoneExt":191,"email":435},{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":462,"status":195,"city":451,"state":425,"zip":463,"country":199,"countryCode":200,"cosmosGeoPoint":464,"geoPoint":466,"contacts":467},"Siteman Cancer Center-South County","63129",{"type":202,"coordinates":465},[455,456],{"lat":456,"lon":455},[468,469],{"name":209,"role":210,"phone":434,"phoneExt":191,"email":435},{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":471,"status":195,"city":451,"state":425,"zip":472,"country":199,"countryCode":200,"cosmosGeoPoint":473,"geoPoint":475,"contacts":476},"Siteman Cancer Center at Christian Hospital","63136",{"type":202,"coordinates":474},[455,456],{"lat":456,"lon":455},[477,478],{"name":209,"role":210,"phone":434,"phoneExt":191,"email":435},{"name":391,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":480,"status":195,"city":481,"state":482,"zip":483,"country":199,"countryCode":200,"cosmosGeoPoint":484,"geoPoint":488,"contacts":489},"NYU Langone Hospital - Long Island","Mineola","New York","11501",{"type":202,"coordinates":485},[486,487],-73.64068,40.74927,{"lat":487,"lon":486},[490,493],{"name":209,"role":210,"phone":491,"phoneExt":191,"email":492},"212-263-4432","cancertrials@nyulangone.org",{"name":494,"role":190,"phone":191,"phoneExt":191,"email":191},"Maya Dimitrova",{"facility":496,"status":195,"city":482,"state":482,"zip":497,"country":199,"countryCode":200,"cosmosGeoPoint":498,"geoPoint":502,"contacts":503},"Laura and Isaac Perlmutter Cancer Center at NYU Langone","10016",{"type":202,"coordinates":499},[500,501],-74.00597,40.71427,{"lat":501,"lon":500},[504,506],{"name":209,"role":210,"phone":191,"phoneExt":191,"email":505},"CancerTrials@nyulangone.org",{"name":494,"role":190,"phone":191,"phoneExt":191,"email":191},{"facility":508,"status":195,"city":509,"state":510,"zip":511,"country":199,"countryCode":200,"cosmosGeoPoint":512,"geoPoint":516,"contacts":517},"University of Pittsburgh Cancer Institute (UPCI)","Pittsburgh","Pennsylvania","15232",{"type":202,"coordinates":513},[514,515],-79.99589,40.44062,{"lat":515,"lon":514},[518,520],{"name":209,"role":210,"phone":519,"phoneExt":191,"email":191},"412-647-8073",{"name":521,"role":190,"phone":191,"phoneExt":191,"email":191},"Diwakar Davar",{"facility":523,"status":195,"city":524,"state":525,"zip":526,"country":199,"countryCode":200,"cosmosGeoPoint":527,"geoPoint":531,"contacts":532},"Huntsman Cancer Institute\u002FUniversity of Utah","Salt Lake City","Utah","84112",{"type":202,"coordinates":528},[529,530],-111.89105,40.76078,{"lat":530,"lon":529},[533,536],{"name":209,"role":210,"phone":534,"phoneExt":191,"email":535},"888-424-2100","cancerinfo@hci.utah.edu",{"name":537,"role":190,"phone":191,"phoneExt":191,"email":191},"Kathleen C. Kerrigan",{"type":539,"investigatorFullName":191,"investigatorTitle":191,"investigatorAffiliation":191,"oldNameTitle":191,"oldOrganization":191},"SPONSOR","100508163","phase-1-immunotherapy-in-combination-with-prednisone-and-sirolimus-for-kidney-transplant-recipients-with-unresectable-or-metastatic-skin-cancer-100508163",false,"NCT05896839","Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer","A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers","Inclusion Criteria:\n\n* Patients must be kidney transplant recipients with a functioning allograft who do not currently require dialysis\n* Patient's age must be \\>= 18 years. Because no dosing or adverse event (AE) data are currently available on the use of nivolumab and ipilimumab in kidney transplant recipients \\\u003C18 years of age, children are excluded from this study, but may be eligible for future pediatric trials\n* Patients must have histologically or cytologically confirmed non-uveal melanoma, basal cell carcinoma, Merkel cell carcinoma, or cutaneous squamous cell carcinoma for which standard non-immunological medical, surgical, or radiation therapy would be insufficient (i.e., patients who are not surgical candidates). Patients with cutaneous squamous cell carcinoma or Merkel cell carcinoma may enroll without prior medical therapy (e.g., cetuximab or chemotherapy respectively). Non-immunologic standard therapies that patients must have received, refused or for which patients were ineligible include:\n\n  * For patients with BRAF-mutant melanoma, prior therapies include BRAF\u002FMEK inhibitors\n  * For patients with Basal cell carcinoma, prior therapies include hedgehog pathway inhibitors\n* Patients must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria, i.e., at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as \\>= 20 mm by chest x-ray or as \\>= 10 mm with CT scan, magnetic resonance imaging (MRI), or calipers by clinical exam is preferred, but not required\n* Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =\\\u003C 2 (Karnofsky \\>= 60%) performance status criteria\n* Leukocytes \\>= 2,000\u002FmcL\n* Absolute neutrophil count \\>= 1,500\u002FmcL\n* Platelets \\>= 50,000\u002FmcL\n* Total bilirubin =\\\u003C 1.5 x institutional upper limit of normal (ULN)\n* Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase \\[SGOT\\])\u002Falanine aminotransferase (ALT) (serum glutamic pyruvic transaminase \\[SGPT\\]) =\\\u003C 2.5 x institutional ULN\n* Serum creatinine =\\\u003C 3 x ULN\n* dd-cfDNA =\\\u003C 1.0% and =\\\u003C 61% increase\n* The effects of nivolumab and ipilimumab on the developing human fetus are unknown. For this reason, and because other therapeutic agents used in this trial are known to be teratogenic, women of childbearing potential (WOCBP) receiving nivolumab must continue contraception for a period of 5 months after the last dose of nivolumab. Women who are not of childbearing potential (i.e., who are postmenopausal or surgically sterile) as well as azoospermic men do not require contraception.\n\nWOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU\u002FL or equivalent units of beta-human chorionic gonadotropin \\[B-HCG\\]) during the screening period. Follow-up evaluations will include interval sexual\u002Fmenstrual histories as needed.\n\nShould a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she (or the participating partner) should inform the treating physician immediately.\n\nWOCBP is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal. Menopause is defined clinically as 12 months of amenorrhea in a woman over 45 in the absence of other biological or physiological causes. Women under the age of 55 must have a documented serum follicle stimulating hormone (FSH) level less than 40 mIU\u002FmL to be considered postmenopausal.\n\n* Human immunodeficiency virus (HIV)-infected patients will be eligible for this trial if they are on effective antiretroviral regimens utilizing non-CYP-interactive agents and have an undetectable viral load. If there is evidence of chronic hepatitis B virus (HBV) infection, HBV viral load must be undetectable on suppressive therapy, if indicated. If there is history of hepatitis C virus (HCV) infection, the patient must have been treated and have undetectable HCV viral load.\n* Ability to understand and the willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants\n\nExclusion Criteria:\n\n* Patients who have received a liver, lung, heart, or pancreas transplant; or allogeneic stem cell transplant; or any kind of bone marrow transplant\n* Patients unwilling or unable to undergo dialysis in the event of allograft failure\n* Patients with prior evidence of human leukocyte antigen (HLA) or non-HLA donor-specific antibodies (DSA)\n* Patients with a history of antibody- or cell-mediated allograft rejection within 3 months of study entry\n* Potential trial participants should have recovered from clinically significant adverse events of their most recent therapy\u002Fintervention prior to enrollment\n* Patients may have received prior anti-PD-(L)1 therapy; however, patients must not have any other checkpoint antibody targeting T-cell co-stimulation within 1 year of study enrollment. Prior history of adjuvant therapy is allowed if received over 1 year prior to enrollment. Prior receipt of oncolytic therapy (e.g., TVEC, RP1) is allowed\n* Patients must not be receiving any other investigational agents\n* Patients with leptomeningeal metastases, more than 3 untreated central nervous system (CNS) metastases, untreated brain metastases measuring \\>1cm, or requiring treatment-dose steroids (\\> 10 mg\u002Fday prednisone equivalents) for CNS-related symptoms. Exclusions are due to concerns regarding progressive neurologic dysfunction that would confound the evaluation of neurologic and other AEs. Patients with brain metastases meeting the above requirements are permitted to enroll\n* Patients must not have a history of severe hypersensitivity reaction to any monoclonal antibody\n* Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to other agents used in the study\n* Patients must not have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or any other significant condition(s) that would make this protocol unreasonably hazardous\n* Pregnant women are excluded from this study because nivolumab and ipilimumab have the potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for AEs in nursing infants secondary to treatment of the mother, breastfeeding should be discontinued if the mother is treated with nivolumab or ipilimumab. These potential risks may also apply to other agents used in this study\n* Patients with autoimmune disease that is active or might recur and affect vital organ function will be eligible only after consultation with the study PI. Guillain-Barre (GB) syndrome, bullous skin disease, Stevens Johnson syndrome, or toxic epidermal necrolysis will be excluded\n* Patients must not have had evidence of active or acute diverticulitis, intra-abdominal abscess, GI obstruction and abdominal carcinomatosis which are known risk factors for bowel perforation should be evaluated for the potential need for additional treatment before coming on study. In addition, patients with a history of cardiac disease including coronary artery disease (CAD), myocardial infarction (MI), cardiomyopathy, arrhythmia, heart block, should have an evaluation by history pulmonary embolism (PE) and appropriate testing to allow evaluation of any events that may occur on study. These may include troponin, electrocardiogram (EKG), echocardiogram (ECHO) as clinically indicated and may include results already in the medical record if available","ALL","18 Years",{"count":550,"type":551},16,"ESTIMATED","INTERVENTIONAL",[554,555],"PHASE1","PHASE2","This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.",[558,559,560,561,562,563,564,565,566,567,568,569,570],"Clinical Stage III Cutaneous Melanoma AJCC v8","Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8","Clinical Stage IV Cutaneous Melanoma AJCC v8","Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8","Metastatic Basal Cell Carcinoma","Metastatic Carcinoma in the Skin","Metastatic Melanoma","Metastatic Merkel Cell Carcinoma","Metastatic Skin Squamous Cell Carcinoma","Unresectable Basal Cell Carcinoma","Unresectable Melanoma","Unresectable Merkel Cell Carcinoma","Unresectable Skin Squamous Cell Carcinoma","2026-06-12",{"date":573,"type":574},"2026-06-15","ACTUAL",{"date":576,"type":574},"2024-07-24",{"date":578,"type":551},"2027-01-31",{"name":5,"class":6},26]